.htm_cmp_balance010_bnr.gif)
Company Profile
Advanced Surgical Systems was founded in 1995 to bridge
the gap between research and commercial equipment for high power, therapeutic ultrasound.
Originally involved in hyperthermia, ablation, and MRI Guided Focused Ultrasound Surgery,
the founders of Advanced Surgical Systems were well aware of the lack of commercially
available amplifier systems capable of driving ultrasound transducers with the desired
power and phase control. This lack of commercial equipment has forced researchers in the
field of therapeutic ultrasound to either develop their own driving equipment in-house or
pay outrageous prices to connect a series of linear amplifiers. Many researchers have
spent much time, money, and effort developing equipment in order to drive their array
designs or perform clinical studies. It is the goal of Advanced Surgical Systems to
provide a series of commercially available, semi-custom ultrasound driving systems that
can meet the strict requirements of accurately and reliably driving high power therapeutic
ultrasound transducers.
The core of Advanced Surgical Systems is comprised of a
team of engineers experienced in driving single element and multi-element transducers,
transducer design, construction, and characterization with piezoceramic and composite
materials, RF amplifier design, computer programming and embedded control, the physics of
acoustics, and clinical research. The concentration of these skills has resulted in the
UDS Series Amplifier Systems -
semi-custom driving systems that have been specifically designed from the ground up to
drive even the most complex transducers.
As the current trend in therapeutic ultrasound is to use
phased and/or multi-element arrays, the driving equipment is therefore complex and
expensive for researchers to manufacture in-house. When driving many elements, significant
tradeoffs exist between the various amplifier designs, the control circuitry, and the
software interfacing to the complete system that must be carefully addressed in order to
produce a safe, reliable, and accurate system. For transducers with a large number of
array elements, the amplifiers must be safe, reliable, and efficient, must occupy a small
space, and at the same time produce spectrally pure sine waves. The system control must
also be safe and reliable while having the ability to control many amplifier channels
simultaneously at a reasonably high speed. The software interfacing must be simple, easy
to use, and provide enough flexibility to custom tailor the driving system to the specific
application. The combined experience of the Advanced Surgical Systems engineers has
resulted in the development of amplifier systems that meet these criteria.
Currently, Advanced Surgical Systems has three
main
driving system designs: the 500-013, the
500-018, and the 500-009
CSA,
a four channel stand alone unit with customizable power and frequency ranges. The first
design offers 60 watts of power per channel in the range of 0.8 -1.25 MHz with
independent power and phase control, while the second design offers 50 watts per channel
in the range of 6-10 MHz with independent frequency and power control. The basic UDS design was developed over several years and has been partially financed through
an SBIR award. Several different versions of the phased array systems and the
frequency systems are described in detail under the
amplifier section.
For more information regarding the specifics of the UDS
Series system design, refer to the Design Considerations of the
UDS Series Amplifier Systems document located elsewhere at this site.
Company Direction
At the current time, there are no FDA approved therapies
utilizing focused ultrasound for hyperthermia or ablation. As a result, Advanced Surgical
Systems' focus has been to develop amplifier systems targeted for therapeutic ultrasound
research. The UDS series amplifiers offer the required characteristics for many ultrasound
applications, including safety and reliability, at a price far less than it would cost to
develop such an extensive system in-house.
However, as the field of therapeutic ultrasound develops,
several applications are maturing to the point of FDA approved clinical use. It is the
goal of Advanced Surgical Systems to continue developing the ultrasound driving
technologies by working with other small companies developing specific therapies in order
to supply emerging clinical systems with the highest performing custom and semi-custom
designed amplifiers capable of driving therapeutic ultrasound transducers.
Currently, Advanced Surgical Systems is registered with
the city of Cambridge as a manufacturer. To improve its ability to manufacture
quality systems that will be approved for clinical use, Advanced Surgical Systems is
implementing GMP/QS and ISO procedures, and it is the goal of the company to become fully
compliant in order to manufacture and distribute clinical systems both in the U.S. and
worldwide.